The effects of octreotide in a patient with Nelson's syndrome.
Department of Internal Medicine, Erciyes University Medical School, 38039 Kayseri-Turkey.
We have administered octreotide, 100 micrograms tid, to a 27-year-old man with Nelson's syndrome. After seven days of therapy, adrenocorticotropin levels fell to 54% of initial values, and some shrinkage of the tumour was observed. This study indicates that octreotide therapy may have a role in the treatment of Nelson's syndrome.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
de Bruin, C, Feelders, R A, Waaijers, A M, van Koetsveld, P M, Sprij-Mooij, D M, Lamberts, S W J, Hofland, L J
(2009). Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro. J Mol Endocrinol
42: 47-56
[Abstract] [Full Text] -
DE HERDER, W W, LAMBERTS, S W J
(1999). Octapeptide somatostatin-analogue therapy of Cushing's syndrome. Postgrad. Med. J.
75: 65-66
[Full Text]
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
